Rio Silver Inc. (‘Rio Silver’ or the ‘Company’) (TSX.V: RYO) (OTC: RYOOF), announces shareholder approval…
Author
admin
-
-
-
-
-
-
-
-
-
Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
by adminRAD 402 preclinical data package complete; demonstrates safety and promising biodistribution profile Ethics approval and…
-